Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
Last updated 26 Jul 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is a rare condition that prevents the body from converting certain fats to energy, particularly during periods without food (fasting).
Video picks for Genetic conditionsVideo library
Description
Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is a rare condition that prevents the body from converting certain fats to energy, particularly during periods without food (fasting).
Signs and symptoms of LCHAD deficiency typically appear during infancy or early childhood. Many affected infants have feeding difficulties, such as an extreme dislike of certain foods or of eating at all (food or feeding aversion), nausea, and vomiting. Other signs and symptoms include lack of energy (lethargy), low blood glucose (hypoglycemia), weak muscle tone (hypotonia), delayed development of milestones, liver problems, and abnormalities in the light-sensitive tissue at the back of the eye (retina). Affected individuals can have impaired vision or difficulty seeing things far away (myopia) or in low light (night blindness). These vision problems worsen over time. Later in childhood, people with this condition may experience muscle pain, breakdown of muscle tissue (rhabdomyolysis), and a loss of sensation in their arms and legs (peripheral neuropathy). Infants and children with LCHAD deficiency are also at risk of serious heart problems, such as a weakened heart (cardiomyopathy) and heart failure; breathing difficulties; coma; and sudden death.
Problems related to LCHAD deficiency can be triggered when the body is under stress, for example during periods of fasting, illnesses such as viral infections, or weather extremes. This disorder is sometimes mistaken for Reye syndrome, a severe disorder that may develop in children while they appear to be recovering from viral infections such as chicken pox or flu. Most cases of Reye syndrome are associated with the use of aspirin during these viral infections.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
3-hydroxyacyl-CoA dehydrogenase, long chain, deficiency
LCHAD deficiency
Long-chain 3-hydroxy acyl CoA dehydrogenase deficiency
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
Long-chain 3-OH acyl-CoA dehydrogenase deficiency
Trifunctional protein deficiency, type 1
Patient picks for Genetic conditions

Chest and lungs
Long COVID
Most people with COVID-19 infection (SARS CoV-2 infection) feel better within a few days or weeks and recover completely within 12 weeks of the infection. However, some people have ongoing symptoms that remain for weeks, months, or longer, which is usually called "long COVID". For some, these long-term effects of COVID-19 can be debilitating. These effects can be very different from person to person, and it seems likely that there are different 'types' of long COVID, or different syndromes, which might behave in different ways.
by Dr Doug McKechnie, MRCGP

Diet and nutrition
Vitamin C: benefits, sources, and deficiency
Most of us know vitamin C is good for us, but do you know all the ways that this essential nutrient benefits your health? Here you can find out how easy it is to get enough vitamin C, as well as what happens when you consume too little and too much.
by Lynn Stephen

Heart health and blood vessels
Coarctation of the aorta
Coarctation of the aorta is a type of congenital heart disease where there is a narrowing in part of the aorta, the main artery that leaves the left side of the heart.
by Dr Toni Hazell, FRCGP

COVID-19
Long COVID: what it is and how to cope
Following the COVID-19 pandemic, some people continue to have symptoms long after recovering from the initial infection. This condition is commonly known as long COVID. It can last for months or even years, and affect your quality of life. While there is currently no cure for long COVID, we look at some practical ways to help manage its symptoms and improve your daily wellbeing.
by Victoria Raw

Senior health
Living with a long-term condition
A long-term condition cannot be cured but its symptoms and complications may be controlled with treatment. Examples are arthritis, asthma, diabetes, epilepsy and high blood pressure. Long-term conditions can have an effect on your role within the family, your job, where you live, your education and your finances. However, there are many sources of support you can access, including health and social services, the government and voluntary organisations.
by Dr Hayley Willacy, FRCGP

Healthy living
Vitamin A deficiency
Vitamins are a group of substances needed in small amounts by the body to maintain health. Vitamin A cannot be made by the human body and so it is an essential part of the diet. Vitamin A is important for healthy eyes, good eyesight (vision), healthy skin and to help you fight infections. Vitamin A is sometimes also called retinol. Foods that contain vitamin A include liver, milk, eggs and fish-liver oils. Another substance called beta carotene (which is found in green leafy and orange/yellow vegetables and fruits) can also be converted by your body to vitamin A. Mild forms of vitamin A deficiency can usually be treated without any long-term problems. Vitamin A deficiency is much more common in low-income countries, where it is often very severe and can cause loss of vision and even death.
by Dr Toni Hazell, FRCGP
Related patient information and medicines

Patient information leaflet
Newborn bloodspot test
If your baby was born prematurely (under 32 weeks) then your baby will need a repeat test when they are 28 days old. Medium-chain acyl-Co-A dehydrogenase deficiency (MCADD)- this is a very rare, but potentially life-threatening, inherited disorder, where fat cannot be broken down by the body as well as usual. Babies with this condition develop.

Patient information leaflet
Can I take Devil's claw and Vitamin C together?
Kidney stones (oxalate) High doses of vitamin C can increase the amount of oxalate in your urine, significantly raising the risk of developing kidney stones, especially if you have a history of them. G6PD deficiency If you have glucose-6-phosphate dehydrogenase (G6PD) deficiency, high doses of vitamin C can cause your red blood cells to break down.

Patient information leaflet
Gout
What is gout? | Patient Explainers Gout causes attacks of pain and swelling in one or more joints. Find out more: [https://patient.info/health/gout-leaflet](https://patient.info/health/gout-leaflet) Follow Patient: Website: [https://patient.info/](https://patient.info/) Facebook: [https://www.facebook.com/patient](https://www.facebook.com/patient).

Patient information leaflet
Can I take Glucosamine and Vitamin C together?
Kidney stones (oxalate) High doses of Vitamin C (typically over 1000mg daily) can increase the amount of oxalate in your urine, significantly raising the risk of developing kidney stones if you are prone to them. G6PD deficiency If you have glucose-6-phosphate dehydrogenase (G6PD) deficiency, high doses of vitamin C can cause your red blood cells.

Patient information leaflet
Can I take Ginger and Vitamin C together?
Kidney stones (Calcium oxalate) High doses of Vitamin C can significantly increase the amount of oxalate in your urine, which may lead to the formation of kidney stones, especially if you have a history of them. G6PD deficiency If you have glucose-6-phosphate dehydrogenase (G6PD) deficiency, high doses of vitamin C can cause your red blood cells.

Patient information leaflet
Can I take Evening primrose oil and Vitamin C together?
Why this happens Evening primrose oil is a source of omega-6 fatty acids (specifically gamma-linolenic acid), while vitamin C is a water-soluble antioxidant. Kidney stones or kidney disease High doses of vitamin C can increase the amount of oxalate in your urine, s... G6PD deficiency If you have glucose-6-phosphate dehydrogenase (G6PD) deficiency,.
Further reading and references
- Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency; MedlinePlus, National Library of Medicine.
- Angdisen J, Moore VD, Cline JM, Payne RM, Ibdah JA. Mitochondrial trifunctional protein defects: molecular basis and novel therapeutic approaches. Curr Drug Targets Immune Endocr Metabol Disord. 2005 Mar;5(1):27-40. doi: 10.2174/1568008053174796.
- den Boer ME, Wanders RJ, Morris AA, IJlst L, Heymans HS, Wijburg FA. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics. 2002 Jan;109(1):99-104. doi: 10.1542/peds.109.1.99.
- Fahnehjelm KT, Holmstrom G, Ying L, Haglind CB, Nordenstrom A, Halldin M, Alm J, Nemeth A, von Dobeln U. Ocular characteristics in 10 children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a cross-sectional study with long-term follow-up. Acta Ophthalmol. 2008 May;86(3):329-37. doi: 10.1111/j.1600-0420.2007.01121.x. Epub 2007 Dec 19.
- Gillingham MB, Purnell JQ, Jordan J, Stadler D, Haqq AM, Harding CO. Effects of higher dietary protein intake on energy balance and metabolic control in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. Mol Genet Metab. 2007 Jan;90(1):64-9. doi: 10.1016/j.ymgme.2006.08.002. Epub 2006 Sep 22.
- Oey NA, den Boer ME, Wijburg FA, Vekemans M, Auge J, Steiner C, Wanders RJ, Waterham HR, Ruiter JP, Attie-Bitach T. Long-chain fatty acid oxidation during early human development. Pediatr Res. 2005 Jun;57(6):755-9. doi: 10.1203/01.PDR.0000161413.42874.74. Epub 2005 Apr 21.
- Prasun P, LoPiccolo MK, Ginevic I. Long-Chain Hydroxyacyl-CoA Dehydrogenase Deficiency / Trifunctional Protein Deficiency. 2022 Sep 1. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK583531/
- Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annu Rev Physiol. 2002;64:477-502. doi: 10.1146/annurev.physiol.64.082201.154705.
- Sims HF, Brackett JC, Powell CK, Treem WR, Hale DE, Bennett MJ, Gibson B, Shapiro S, Strauss AW. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):841-5. doi: 10.1073/pnas.92.3.841.
- Spiekerkoetter U, Lindner M, Santer R, Grotzke M, Baumgartner MR, Boehles H, Das A, Haase C, Hennermann JB, Karall D, de Klerk H, Knerr I, Koch HG, Plecko B, Roschinger W, Schwab KO, Scheible D, Wijburg FA, Zschocke J, Mayatepek E, Wendel U. Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop. J Inherit Metab Dis. 2009 Aug;32(4):488-97. doi: 10.1007/s10545-009-1125-9. Epub 2009 Apr 29.
- Tyni T, Paetau A, Strauss AW, Middleton B, Kivela T. Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res. 2004 Nov;56(5):744-50. doi: 10.1203/01.PDR.0000141967.52759.83. Epub 2004 Sep 3.
- Tyni T, Pihko H. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Acta Paediatr. 1999 Mar;88(3):237-45. doi: 10.1080/08035259950169954.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

